| Literature DB >> 30719285 |
Ruairi P McDonnell1,2, John V O' Doherty1, Bernadette Earley3, Anne Marie Clarke1, David A Kenny1,3.
Abstract
BACKGROUND: Previous research in both calves and other species has suggested n-3 polyunsaturated fatty acids (PUFA) and β-glucans may have positive effects on immune function. This experiment measured performance, behaviour, metabolite and immunological responses to pre-weaning supplementation of dairy bull calves with n-3 PUFA in the form of fish oil and β-glucans derived from seaweed extract. 44 Holstein Friesian bull calves, aged 13.7 ± 2.5 d and weighing 48.0 ± 5.8 kg were artificially reared using an electronic feeding system. Each calf was offered 5 L (120 g/L) per day of milk replacer (MR) and assigned to one of four treatments included in the MR, (1) Control (CON); (2) 40 g n-3 PUFA per day (FO); (3) 1 g β-glucans per day (GL) and (4) 40 g n-3 PUFA per day & 1 g/d β-glucans (FOGL) in a 2 × 2 factorial design. Milk replacer and concentrate was offered from d 0-62 (pre-weaning), while concentrate provision continued for a further 31 d post-weaning period. Individual daily feed intake and feeding behaviour was recorded throughout, while bodyweight and blood analyte data were collected at regular intervals.Entities:
Keywords: Fish oil; Fucoidan; Immune function; Laminarin; Preweaning; Seaweed
Year: 2019 PMID: 30719285 PMCID: PMC6350401 DOI: 10.1186/s40104-019-0317-x
Source DB: PubMed Journal: J Anim Sci Biotechnol ISSN: 1674-9782
Fatty acid composition of fish oil (% of total fatty acids)
| Fatty acid | Fish oil ( |
|---|---|
| C14:0 | 0.14 ± 0.01 |
| C15:1 | 0.14 ± 0.09 |
| C16:0 | 2.27 ± 0.35 |
| C16:1 | 1.04 ± 0.06 |
| C17:0 | 0.19 ± 0.07 |
| C17:1 | 0.07 ± 0.01 |
| C18:0 | 3.64 ± 0.21 |
| C18:1 | 5.70 ± 0.45 |
| C18:1 | 0.08 ± 0.01 |
| C18:2 | 1.54 ± 0.02 |
| C18:3 | 0.89 ± 0.04 |
| C18:3 | 0.19 ± 0.02 |
| C20:1 | 3.36 ± 0.10 |
| C20:2 | 3.00 ± 0.22 |
| C20:3 | 0.32 ± 0.03 |
| C20:3 | 0.43 ± 0.04 |
| C20:4 | 1.98 ± 0.09 |
| C20:5 | 39.05 ± 0.54 |
| C22:0 | 0.50 ± 0.04 |
| C22:1 | 1.31 ± 0.32 |
| C22:2 | 2.37 ± 0.04 |
| C22:6 | 24.25 ± 0.14 |
| C24:0 | 0.47 ± 0.09 |
| C24:1 | 0.28 ± 0.02 |
Chemical composition of concentrates and calf milk replacer
| Item | Concentrates | Milk replacer |
|---|---|---|
| DM, g/kg | 912 | – |
| Crude protein, g/kg DM | 181 | 228 |
| Ash, g/kg DM | 66 | – |
| ADF, g/kg DMa | 136 | – |
| NDF, g/kg DMb | 407 | – |
| Gross energy, MJ/kg DM | 168 | 203 |
| Percentage oil, g/kg DM | 21 | 161 |
aADF Acid detergent fibre
bNDF Neutral detergent fibre
Effect of FO and GL supplementation on feed intake in the pre- and post-weaning periods
| Trait | Fish Oil (FO) | β -Glucans (GL) | Period (P) relative to weaning | Interactionsb | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | + | SED | – | + | SED | Pre | Post | SED | FO | GL | P | FO×GL | P×FO | P×GL | |
| Milk replacer, litres/d | 4.65 | 4.66 | 0.034 | 4.67 | 4.64 | 0.034 | 4.66 | n/a | n/a | 0.80 | 0.45 | n/a | 0.038 | n/a | n/a |
| Concentrates, kg DM/d | 1.20 | 0.99 | 0.018 | 1.32 | 0.86 | 0.019 | 0.61 | 1.58 | 0.026 | <.0001 | <.0001 | <.0001 | 0.0013 | ns | <.0001 |
| Total GEI, MJ/da | 25.44 | 21.96 | 0.307 | 27.36 | 20.03 | 1.714 | 21.62 | 25.78 | 0.510 | <.0001 | <.0001 | <.0001 | 0.0082 | 0.02 | <.0001 |
aTotal Gross Energy Intake –Includes gross energy of FO (37 MJ/kg) and/or GL (16 MJ/kg) where appropriate
bNo FO×GL×P interactions were detected. Interactions are described in the text when significant
ns not significant, n/a not applicable
Effect of fish oil and β-glucans supplementation in calf milk replacer on feeding behaviour
| No. of visits per day where: | Fish Oil (FO) | β-Glucans (GL) | Period (P) relative to weaning | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | + | SED | – | + | SED | Pre | Post | SED | FO | GL | P | FO×GL | FO×P | GL×P | FO×GL×P | |
| Milk consumed | 3.45 | 3.62 | 0.164 | 3.50 | 3.57 | 0.164 | – | – | – | 0.29 | 0.68 | – | ns | – | – | – |
| Milk not consumed | 11.85 | 11.66 | 1.102 | 13.08 | 10.44 | 1.103 | – | – | – | 0.87 | 0.02 | – | ns | – | – | – |
| Drinking rate, L/min | 1.09 | 1.21 | 0.053 | 1.15 | 1.15 | 0.053 | – | – | – | 0.02 | 0.85 | – | ns | – | – | – |
| Visits where concentrate was consumed, visits/d | 19.38 | 20.42 | 1.798 | 21.61 | 18.20 | 1.798 | 20.84 | 18.97 | 0.638 | 0.29 | 0.056 | 0.003 | 0.071 | <.0001 | ns | <.0001 |
| Time in concentrate feeder, min/d | 55.40 | 51.45 | 2.894 | 56.99 | 49.86 | 2.893 | 39.56 | 67.29 | 1.091 | 0.17 | 0.014 | <.0001 | ns | <.0001 | ns | ns |
aInteractions are described in the text when significant
ns not significant
Effect of FO and GL supplementation on animal performance, rectal temperature and fecal scores
| Fish Oil (FO) | β-Glucans (GL) | Period (P) relative to weaning | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | + | SED | – | + | SED | Pre | Post | Post-turnout | SEM | FO | GL | P | FO×GL | FO×P | GL×P | |
| Start weight, kg | 48.7 | 48.1 | 0.43 | 48.5 | 48.3 | 0.42 | ns | ns | ns | ns | ns | |||||
| Weaning weight, kga | 66.1 | 60.0 | 0.39 | 65.2 | 60.9 | 0.39 | <.0001 | <.0001 | ns | ns | ns | |||||
| Turnout weight, kgb | 108.4 | 95.8 | 0.95 | 110.0 | 94.1 | 0.95 | <.0001 | <.0001 | ns | ns | ns | |||||
| End weight, kgc | 162.4 | 152.6 | 1.48 | 162.4 | 152.6 | 1.45 | <.0001 | <.0001 | 0.04 | ns | ns | |||||
| ADG, kg/dd | 0.78 | 0.71 | 0.042 | 0.81 | 0.68 | 0.042 | 0.31 | 1.14 | 0.78 | 0.022 | 0.060 | 0.001 | <.0001 | ns | <.0001 | <.0001 |
| Fecal scoree | 2.15 | 2.15 | 0.080 | 2.1 | 2.2 | 0.08 | 2.06 | 2.24 | 0.056 | 0.984 | 0.098 | 0.002 | ns | ns | ns | |
| Rectal temperature, | 38.86 | 38.63 | 0.057 | 38.69 | 38.81 | 0.057 | 38.69 | 38.81 | 0.046 | < 0.0001 | 0.035 | 0.011 | ns | ns | ns | |
aWeaning weight = weight at end of milk feeding period
bTurnout weight = weight at end of concentrate feeding and before turn out to grass
cEnd weight = weight after 3 months at grass
dADG = Average daily gain over a 172-day period starting on d 0 of the experiment
eFecal score ranged from 1 to 4; 1 = firm, 2 = semi-solid, 3 = liquid, 4 = very liquid
fInteractions are described in the text when significant
ns not significant
Effect of FO and GL supplementation on plasma concentrations of selected fatty acid methyl esters (FAME) as a % of total FAME
| Fish oil (FO) | β-Glucans (GL) | Timingc | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | + | SED | – | + | SED | 1 | 2 | SED | FO | GL | T | FO × GL | FO × T | FO × GL × T | |
| C16 | 15.1 | 20.5 | 1.70 | 18.2 | 17.5 | 1.70 | 13.0 | 22.6 | 1.70 | 0.003 | 0.684 | <.0001 | 0.074 | ns | 0.0321 |
| C16:1 | 16.7 | 14.7 | 1.40 | 14.9 | 16.5 | 1.36 | 22.2 | 9.2 | 1.50 | 0.168 | 0.257 | <.0001 | ns | ns | ns |
| C18 | 8.0 | 8.2 | 0.68 | 8.6 | 7.7 | 0.68 | 5.7 | 10.6 | 0.68 | 0.817 | 0.193 | <.0001 | 0.015 | 0.053 | 0.0388 |
| C18:1 | 7.3 | 6.8 | 0.57 | 7.2 | 7.0 | 0.57 | 6.8 | 7.3 | 0.57 | 0.459 | 0.721 | 0.442 | ns | ns | ns |
| C18:2 | 22.0 | 12.0 | 1.09 | 18.2 | 15.9 | 1.09 | 7.9 | 26.2 | 1.09 | <.0001 | 0.038 | <.0001 | ns | <.0001 | ns |
| C20 + C20:1 | 1.3 | 1.5 | 0.20 | 1.3 | 1.5 | 0.21 | 1.8 | 1.0 | 0.21 | 0.203 | 0.240 | 0.001 | ns | ns | ns |
| C22:1 | 1.0 | 1.4 | 0.22 | 1.1 | 1.2 | 0.21 | 1.2 | 1.1 | 0.22 | 0.128 | 0.668 | 0.612 | ns | 0.035 | ns |
| EPA | 0.938 | 5.616 | 1.02 | 4.056 | 5.617 | 0.807 | ndb | 7.2 | 2.94 | 0.0003 | 0.166 | <.0001 | ns | <.0001 | ns |
| DHA | 0.010 | 0.830 | 0.05 | 1.045 | 0.401 | 0.34 | nd | 1.1 | – | <.0001 | 0.338 | – | ns | 0.001 | ns |
aNo significant GL × Timing interactions observed (P > 0.05). Interactions are described in the text when significant
bNon detectable
cBlood sample timing; Timing 1 = d 0 (pre-supplementation), Timing 2 = d 29
Effect of FO and GL supplementation on plasma concentrations of metabolic hormones and metabolites
| Fish Oil (FO) | β-Glucans (GL) | Period (P) relative to weaning | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | + | SED | – | + | SED | Pre | Peri | Post | SED | FO | GL | P | FO×GL | FO×P | GL×P | |
| Hormones | ||||||||||||||||
| Insulin, μIU/mL | 2.65 | 1.56 | 0.197 | 2.31 | 1.89 | 0.197 | 2.59 | 1.31 | 2.40 | 0.311 | 0.005 | 0.338 | <.0001 | 0.0064 | 0.037 | ns |
| IGF, ng/mL | 107.56 | 66.98 | 16.091 | 103.77 | 70.77 | 16.087 | 79.37 | 62.04 | 120.40 | 10.368 | 0.012 | 0.173 | <.0001 | ns | 0.057 | <.0001 |
| Metabolites, mmol/L | ||||||||||||||||
| Glucose | 4.00 | 3.55 | 0.139 | 3.99 | 3.55 | 0.139 | 3.78 | 3.57 | 3.97 | 0.139 | 0.001 | 0.002 | 0.0001 | ns | ns | 0.058 |
| ΒHBA | 0.27 | 0.27 | 0.018 | 0.26 | 0.29 | 0.018 | 0.12 | 0.31 | 0.38 | 0.011 | 0.930 | 0.195 | <.0001 | ns | ns | ns |
| Urea | 2.65 | 3.12 | 0.158 | 2.83 | 2.93 | 0.158 | 2.60 | 2.91 | 3.13 | 0.134 | 0.003 | 0.370 | 0.003 | ns | 0.003 | ns |
aInteractions are described in the text when significant
ns not significant
Effect of FO and GL supplementation in calf milk replacer on haematology variables
| Fish Oil (FO) | β-Glucans (GL) | Period (P) relative to weaning | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | + | SED | – | + | SED | Pre | Peri | Post | SED | FO | GL | P | |
| Haptoglobin, mg/mL | 0.28 | 0.26 | 0.024 | 0.25 | 0.30 | 0.024 | 0.34 | 0.26 | 0.22 | 0.022 | 0.057 | 0.034 | <.0001 |
| WBCa, × 103 cells/μL | 11.2 | 9.4 | 1.28 | 10.6 | 10.0 | 0.54 | 9.8A | 10.5B | 10.6B | 0.28 | 0.185 | 0.272 | 0.004 |
| RBCb, × 106 cells/μL | 23.2 | 23.0 | 1.14 | 23.1 | 23.1 | 0.44 | 23.5A | 22.6B | 23.2A | 0.17 | 0.940 | 0.927 | <.0001 |
| Neutrophils, % | 29.1 | 29.0 | 1.81 | 27.5 | 30.6 | 1.81 | 27.7A | 28.4A | 31.1B | 1.31 | 0.913 | 0.149 | 0.009 |
| Lymphocytes, % | 56.5 | 57.5 | 1.92 | 59.2 | 54.8 | 1.92 | 58.2 | 56.6 | 56.3 | 1.11 | 0.568 | 0.027 | 0.114 |
| Monocytes, % | 10.4 | 9.9 | 0.58 | 9.9 | 10.4 | 0.58 | 10.3A | 10.7A | 9.5B | 0.33 | 0.444 | 0.345 | 0.001 |
| Leukocyte, % | 0.70 | 0.86 | 0.138 | 0.74 | 0.83 | 0.050 | 0.79A | 0.84AB | 0.72AB | 0.044 | 0.379 | 0.427 | 0.001 |
| Osmolality | 6.09 | 6.12 | 0.086 | 6.00 | 6.20 | 0.086 | 5.77A | 6.30B | 6.23B | 0.065 | 0.716 | 0.021 | <.0001 |
| IFN- γ PHAc | 0.61 | 0.49 | 0.074 | 0.64 | 0.47 | 0.074 | 0.71A | 0.54B | 0.41C | 0.055 | 0.162 | 0.019 | <.0001 |
| IFN- γ Con Ad | 1.11 | 1.02 | 0.072 | 1.16 | 0.97 | 0.072 | 1.17A | 1.04B | 0.99AB | 0.047 | 0.234 | 0.012 | 0.009 |
aWhite blood cells
bRed blood cells
cIFN- γ PHA = Lymphocyte interferon gamma production in response to phytohaemagglutinin A expressed as absorbance at 450 nm
dIFN- γ Con A = Lymphocyte interferon gamma production in response to concanavalin A expressed as absorbance at 450 nm
eThere were no interactions between the main effects detected for haematology variables with the exception of a FO × P interaction for haptoglobin where during the peri-weaning period there was a strong tendency (P = 0.053) for FO supplemented calves to have lower haptoglobin concentrations compared with un-supplemented calves (Peri-weaning: 0.22 vs 0.30 mg/mL; SED = 0.035) for FO+ vs FO–), however no differences were detected in either the pre- or post-weaning periods
A-CMeans within a row with different superscripts differ significantly (P < 0.05)